APA

Chakrabarti G., Silvers M. A., Ilcheva M., Liu Y., Moore Z. R., Luo X., Gao J., Anderson G., Liu L., Sarode V., Gerber D. E., Burma S., DeBerardinis R. J., Gerson S. L. & Boothman D. A. (20160921). Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone. : Scientific reports.

Chicago

Chakrabarti Gaurab, Silvers Molly A, Ilcheva Mariya, Liu Yuliang, Moore Zachary R, Luo Xiuquan, Gao Jinming, Anderson Glenda, Liu Lili, Sarode Venetia, Gerber David E, Burma Sandeep, DeBerardinis Ralph J, Gerson Stanton L and Boothman David A. 20160921. Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone. : Scientific reports.

Harvard

Chakrabarti G., Silvers M. A., Ilcheva M., Liu Y., Moore Z. R., Luo X., Gao J., Anderson G., Liu L., Sarode V., Gerber D. E., Burma S., DeBerardinis R. J., Gerson S. L. and Boothman D. A. (20160921). Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone. : Scientific reports.

MLA

Chakrabarti Gaurab, Silvers Molly A, Ilcheva Mariya, Liu Yuliang, Moore Zachary R, Luo Xiuquan, Gao Jinming, Anderson Glenda, Liu Lili, Sarode Venetia, Gerber David E, Burma Sandeep, DeBerardinis Ralph J, Gerson Stanton L and Boothman David A. Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone. : Scientific reports. 20160921.